Amuvatinib (MP-470) - ≥98%, high purity , Platelet-derived growth factor receptor alpha inhibitor, CAS No.850879-09-3, Platelet-derived growth factor receptor alpha inhibitor

Item Number

M127412

• Synonyms: Amuvatinib | 850879-09-3 | MP-470 | MP470 | MP 470 | Amuvatinib (MP-470) | HPK56 | HPK 56 | HPK-56 | N-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide | N-(1,3-benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)piperaz
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Amuvatinib is a potent and multi-targeted tyrosine kinase inhibitor that inhibits c-Kit and PDGFα and has been shown to induce apoptosis.
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Platelet-derived growth factor receptor alpha inhibitor
• Note: 卖完停产，不再备货

Product Description

Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively.
A multi-targeted tyrosine kinase inhibitor of PDGF and c-Kit。